Perspective
Published in:
Volume 13 / Year 2024 / Issue 1
Volume 13 / Year 2024 / Issue 1
Current understanding, knowledge, and perception of biosimilars in a changing landscape of regulatory requirements
Page: 27-33
Author byline as per print journal: Andriy Krendyukov, MD, PhD; Marta Bakowska, BA (Hon), MPH; Dirk Schiller, PhD; Sanjay Singhvi, BSc (Hon), MBBS, MBA Introduction: Healthcare providers often lack familiarity… Read More »
Comparative efficacy studies of biosimilars: data versus theoretical risks, beliefs, and comfort
Author(s): Adjunct Professor Pekka Kurki, MD, PhD
Page: 23-6
Page: 23-6
Abstract: In principle, biosimilars could mitigate the problem of the rising cost of biological medicines. However, the current stringent and non-harmonized regulatory practices hinder competition and contribute to the high… Read More »